通过抑制PARP,通过增强瘤中的HLA-G表达,引起NK细胞相关的免疫逃避
Siyuan Wang1, Yu Xia2, Yiyu Qian2
1Cancer Biology Research Center (Key Laboratory of Chinese Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Ave, Wuhan 430030, China; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, China.
聚 ((ADP-ribose) 聚合酶抑制剂 (PARPi) 增加了自然杀手 (NK) 细胞的透,但也提高了免疫检查点HLA-G的调节. 将PARPi与HLA-G阻断相结合,可以增强NK细胞抗瘤活性和抑制瘤生长.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐受性对多ADP-ribose聚合酶抑制剂 (PARPi) 的耐药性限制了癌症治疗的有效性.
- 瘤免疫微环境调节对于PARPi反应至关重要.
- 了解PARPi与抗瘤免疫的相互作用是优化组合疗法的必要条件.
研究的目的:
- 为了研究PARPi (niraparib) 对抗瘤免疫反应的影响.
- 阐明PARPi影响自然杀手 (NK) 细胞功能的机制.
- 评估将尼拉巴里布与免疫检查点封锁结合的疗效.
主要方法:
- 来自新辅助药尼拉巴里布单疗法前性临床试验 (NCT04507841) 的瘤样本的分析.
- 对NK细胞透和细胞毒性功能的评估.
- 研究人类白细胞抗原G (HLA-G) 表达及其在瘤细胞中由niraparib调节的情况.
- 在体外和体内研究结合了niraparib与HLA-G阻断.
主要成果:
- 尼拉巴里布治疗增加了NK细胞的透,但并没有增加其细胞毒性功能.
- 尼拉巴通过EGFR内部化,减少AKT/mTOR信号传递和增加TFEB活性,提高了瘤细胞中HLA-G表达的调节,特别是那些具有野生型EGFR的瘤细胞.
- 尼拉帕里布与HLA-G阻断的结合在体外增强了NK细胞介导的瘤溶解.
- 结合疗法在人性化的患者衍生异种移植模型中协同抑制瘤生长.
结论:
- 尼拉帕里布通过上调HLA-G来诱导免疫逃避机制,这阻碍了NK细胞的功能.
- 与PARPi结合阻断HLA-G可以克服这种抵抗.
- 这种组合方法有望通过增强NK细胞介导的抗瘤免疫力来提高癌症治疗疗效.
相关概念视频
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...


